Bussalb Aurore, Congedo Marco, Barthélemy Quentin, Ojeda David, Acquaviva Eric, Delorme Richard, Mayaud Louis
Mensia Technologies SA, Paris, France.
Child and Adolescent Psychiatry Department, Robert Debré Hospital, Paris, France.
Front Psychiatry. 2019 Feb 18;10:35. doi: 10.3389/fpsyt.2019.00035. eCollection 2019.
Meta-analyses have been extensively used to evaluate the efficacy of neurofeedback (NFB) treatment for Attention Deficit/Hyperactivity Disorder (ADHD) in children and adolescents. However, each meta-analysis published in the past decade has contradicted the methods and results from the previous one, thus making it difficult to determine a consensus of opinion on the effectiveness of NFB. This works brings continuity to the field by extending and discussing the last and much controversial meta-analysis by Cortese et al. (1). The extension comprises an update of that work including the latest control trials, which have since been published and, most importantly, offers a novel methodology. Specifically, NFB literature is characterized by a high technical and methodological heterogeneity, which partly explains the current lack of consensus on the efficacy of NFB. This work takes advantage of this by performing a Systematic Analysis of Biases (SAOB) in studies included in the previous meta-analysis. Our extended meta-analysis (k = 16 studies) confirmed the previously obtained results of effect sizes in favor of NFB efficacy as being significant when clinical scales of ADHD are rated by parents (non-blind, -value = 0.0014), but not when they are rated by teachers (probably blind, -value = 0.27). The effect size is significant according to both raters for the subset of studies meeting the definition of "standard NFB protocols" (parents' -value = 0.0054; teachers' -value = 0.043, k = 4). Following this, the SAOB performed on k = 33 trials identified three main factors that have an impact on NFB efficacy: first, a more intensive treatment, but not treatment duration, is associated with higher efficacy; second, teachers report a lower improvement compared to parents; third, using high-quality EEG equipment improves the effectiveness of the NFB treatment. The identification of biases relating to an appropriate technical implementation of NFB certainly supports the efficacy of NFB as an intervention. The data presented also suggest that the assessment of teachers may not be considered a good proxy for blind assessments, therefore stressing the need for studies with placebo-controlled intervention as well as carefully reported neuromarker changes in relation to clinical response.
荟萃分析已被广泛用于评估神经反馈(NFB)治疗儿童和青少年注意力缺陷多动障碍(ADHD)的疗效。然而,过去十年发表的每一项荟萃分析都与前一项的方法和结果相矛盾,因此难以就NFB的有效性达成共识。这项工作通过扩展和讨论Cortese等人(1)最近一项备受争议的荟萃分析,为该领域带来了连续性。扩展内容包括对该工作的更新,纳入了此后发表的最新对照试验,最重要的是,提供了一种新颖的方法。具体而言,NFB文献的特点是技术和方法高度异质性,这在一定程度上解释了目前对NFB疗效缺乏共识的原因。这项工作利用了这一点,对先前荟萃分析中纳入的研究进行了偏倚系统分析(SAOB)。我们的扩展荟萃分析(k = 16项研究)证实了先前获得的效应大小结果,即当父母对ADHD临床量表进行评分时(非盲法,P值 = 0.0014),支持NFB疗效的结果具有显著性,但当教师进行评分时(可能为盲法,P值 = 0.27)则不然。对于符合“标准NFB方案”定义的研究子集,根据两位评估者的评估,效应大小均具有显著性(父母的P值 = 0.0054;教师的P值 = 0.043,k = 4)。在此之后,对k = 33项试验进行的SAOB确定了影响NFB疗效的三个主要因素:第一,更强化的治疗与更高的疗效相关,但治疗持续时间无关;第二,教师报告的改善程度低于父母;第三,使用高质量的脑电图设备可提高NFB治疗的有效性。识别与NFB适当技术实施相关的偏倚肯定支持了NFB作为一种干预措施的疗效。所呈现的数据还表明,教师的评估可能不能被视为盲法评估的良好替代方法,因此强调需要进行安慰剂对照干预研究以及仔细报告与临床反应相关的神经标志物变化。